Fred Hassan - Nov 14, 2021 Form 4 Insider Report for Prometheus Biosciences, Inc. (RXDX)

Role
Director
Signature
/s/ Timothy K. Andrews, attorney-in-fact for Fred Hassan
Stock symbol
RXDX
Transactions as of
Nov 14, 2021
Transactions value $
$0
Form type
4
Date filed
11/16/2021, 08:19 PM
Previous filing
Aug 26, 2021
Next filing
Jan 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXDX Stock Option (Right to Buy) Award $0 +541 $0.00 541 Nov 14, 2021 Common Stock 541 $36.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the first anniversary of the vesting commencement date measured from November 14, 2021, subject to the Reporting Person's continued service with the Issuer on such vesting date.